PublizoomRoche Pharma AG
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 3
- Amount won alone
- €216,000 excl. VAT
- Shared contracts
- 2 (multi-supplier framework agreements)
- Period
- 2 September 2026 – 1 October 2026
Its main clients
- DAK-Gesundheit · 2 contracts
- AOK Baden-Württemberg · 1 contract
Where and what
Supplies · 3
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 1 December 2027 re-tender around June 2027 |
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Fertigspritze und Fertigpen), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027
DAK-Gesundheit |
Abacus Medicine A/S 1 0 1 Carefarm GmbH CC Pharma GmbH EurimPharm Arzneimittel GmbH kohlpharma GmbH Orifarm GmbH Originalis B.V. Paranova Pack A/S Roche Pharma AG 2care4 ApS Aaragon Pharma s.r.o B2B Medical GmbH ACA Müller ADAG Pharma AG Celltrion Healthcare Deutschland GmbH Fresenius Kabi Deutschland GmbH Gedeon Richter Pharma GmbH Medicopharm AG 9 bids received |
€1 |
| 30 September 2028 re-tender around March 2028 |
Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zum Wirkstoff Crovalimab
AOK Baden-Württemberg framework agreement |
Roche Pharma AG 1 bid received |
€216,000 |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.